Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001643918-23-000002
Filing Date
2023-06-07
Accepted
2023-06-06 19:17:29
Documents
1
Effectiveness Date
2023-06-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9801
  Complete submission text file 0001643918-23-000002.txt   11039
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-483522 | Film No.: 23997386
SIC: 2834 Pharmaceutical Preparations